Jian-Hua Hong
Overview
Explore the profile of Jian-Hua Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fang J, Yeh H, Lee H, Weng H, Tai T, Huang C, et al.
BMC Urol
. 2024 Oct;
24(1):231.
PMID: 39434129
Background: Nephroureterectomy with bladder cuff excision is the standard treatment for high-risk upper urinary tract urothelial carcinoma (UTUC). The role of minimally invasive surgery in treating locally advanced UTUC remains...
2.
Hong J, Chu C, Tsai D, Liao E, Yeh H
Med Educ
. 2024 Aug;
59(2):173-181.
PMID: 39089743
Purpose: The transition from medical student to practicing physician affects the complex processes of professional identity formation and professionalism, which have a lasting effect on the physician's career development. This...
3.
Chang C, Yu P, Hsieh P, Hong J, Chiang C, Cheng H, et al.
J Chin Med Assoc
. 2024 Jun;
87(7):678-685.
PMID: 38829960
Background: Multiparametric magnetic resonance imaging (mpMRI) followed by MRI-targeted prostate biopsy is the current standard for diagnosing prostate cancer (PCa). However, studies evaluating the value of biomarkers, including prostate health...
4.
Chen C, Chang C, Yang C, Hsieh K, Tsing W, Chen I, et al.
World J Urol
. 2024 Jan;
42(1):22.
PMID: 38197890
Purpose: To evaluate predictive factors of increasing intravesical recurrence (IVR) rate in patients with upper tract urothelial carcinoma (UTUC) after receiving radical nephroureterectomy (RNUx) with bladder cuff excision (BCE). Materials...
5.
Hong J, Kuo M, Cheng Y, Lu Y, Huang C, Liu S, et al.
World J Mens Health
. 2023 Oct;
42(3):587-599.
PMID: 37853534
Purpose: Active surveillance (AS) is one of the management options for patients with low-risk and select intermediate-risk prostate cancer (PC). However, factors predicting disease reclassification and conversion to active treatment...
6.
Chen Y, Yeh H, Lee H, Hsieh P, Chou E, Tsai Y, et al.
Asian J Surg
. 2023 Aug;
46(8):3058-3065.
PMID: 37525448
Background: Endoscopic management of upper tract urothelial cancer (UTUC) is an important treatment option for low risk UTUC. Although Taiwan is an endemic area for UTUC, endoscopic treatment outcomes in...
7.
Lu Y, Ho C, Hong J, Kuo M, Liao Y, Jaw F, et al.
Mol Oncol
. 2023 Mar;
17(8):1613-1627.
PMID: 36931723
Extracellular vesicles (EVs) are an important regulatory factor for natural killer cell activity (NKA) in the tumor microenvironment. The relationship between circulating EVs in the peripheral blood and natural killer...
8.
Che T, Chiu C, Wu Y, Chen J, Chou T, Cheng Y, et al.
Lung Cancer
. 2023 Mar;
178:198-205.
PMID: 36871344
Introduction: Circulating tumor cells (CTCs) and their proliferative ability in lung adenocarcinoma (LUAD) were not well-investigated. We developed a protocol combining an efficient viable CTC isolation and in-vitro cultivation for...
9.
Shao Y, Hong J, Chen C, Huang C
Prostate Cancer Prostatic Dis
. 2022 Oct;
26(3):633-634.
PMID: 36216968
No abstract available.
10.
Lu Y, Kuo M, Hong J, Jaw F, Huang C, Cheng J, et al.
J Formos Med Assoc
. 2022 Aug;
121(9):1883.
PMID: 36028302
No abstract available.